Continuing Education
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Drug Information Association designates this educational activity for up to 6.5 contact hour or .65 CEUs.
Credit Allocation:
Introduction to Drug Development: 1 contact hours or .1 CEUs. UAN: 0286-0000-18-046-H04-P Type of Activity: Application
Discovery and Pre-Clinical Phases: 1 contact hours or .1 CEUs. UAN: 0286-0000-18-047-H04-P Type of Activity: Application
Drug Development Phase 1: 1 contact hours or .1 CEUs. UAN: 0286-0000-18-048-H04-P Type of Activity: Application
Drug Development Phase 2: 1.25 contact hours or .125 CEUs. UAN: 0286-0000-18-049-H04-P Type of Activity: Application
Drug Development Phase 3 and Regulatory Review: 1.5 contact hours or .15 CEUs. UAN: 0286-0000-18-050-H04-P Type of Activity: Application
Drug Development Phase 4 and Lifecycle Management: .75 contact hours or .75 CEUs. UAN: 0286-0000-18-051-H04-P Type of Activity: Knowledge
DIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI®). This program offers a maximum of 6.5 professional development units (PDUs).
Credit Allocation:
Introduction to Drug Development: 1 PDU PMI #: 2166-000219
Discovery and Pre-Clinical Phases: 1 PDU PMI #: 2166-000234
Drug Development Phase 1: 1 PDU PMI #: 2166-000235
Drug Development Phase 2: 1.25 PDU PMI #: 2166-000236
Drug Development Phase 3 and Regulatory Review: 1.5 PDU PMI #: 2166-000237
Drug Development Phase 4 and Lifecycle Management: .75 PDU PMI #: 2166-000238
The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.
Drug Information Association (DIA) is accredited by the International Association for Continuing Education and Training (IACET) and is authorized to issue the IACET CEU.
As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .7 CEUs for this program.
Credit Allocation:
Introduction to Drug Development: .1 CEU
Discovery and Pre-Clinical Phases: .1 CEU
Drug Development Phase 1: .1 CEU
Drug Development Phase 2 : .1 CEU
Drug Development Phase 3 and Regulatory Review: .2 CEU
Drug Development Phase 4 and Lifecycle Management: .1 CEU
This event is approved by the Regulatory Affairs Professionals Society for 6 RAC credits.
Statement of Credit:
Statement of Credit and Successful Completion Requirements
To successfully complete this course and receive a statement of credit, you must review at least 90% of the module, achieve a passing score of 80% or better on the post-assessment, and complete the evaluation.
After a module is completed, you will be able to access the module for one year from the date of purchase.
Sign in to My Account to access My Transcripts and request your online credit.
Have an account?